Evidence map›Paper›PMID 35013572›Full record

ArticleMucosal immunology2022

Glutaminolysis is required in maintaining immune regulatory functions in B cells.

Jiang-Qi Liu, Xiao-Rui Geng, Tian-Yong Hu, Li-Hua Mo, Xiang-Qian Luo, Shu-Yao Qiu, Da-Bo Liu, Zhi-Gang Liu, Jian-Bo Shao, Zhi-Qiang Liu and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jiang-Qi Liu *Department of Otolaryngology, Longgang E.N.T hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T Shenzhen, Shenzhen, China.
Xiao-Rui Geng *Department of Otolaryngology, Longgang E.N.T hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T Shenzhen, Shenzhen, China.
Tian-Yong Hu *Department of Otolaryngology, Longgang E.N.T hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T Shenzhen, Shenzhen, China.
Li-Hua MoGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China.
Xiang-Qian LuoDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Shu-Yao QiuDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Da-Bo LiuDepartment of Pediatric Otolaryngology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Zhi-Gang LiuGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Shenzhen, China.
Jian-Bo ShaoDepartment of Otolaryngology, Beijing Children Hospital, Beijing, China.
Zhi-Qiang LiuDepartment of Otolaryngology, Longgang E.N.T hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T Shenzhen, Shenzhen, China. liuzhiqiang05312438@126.com.
Ping-Chang YangDepartment of Otolaryngology, Longgang E.N.T hospital & Shenzhen Key Laboratory of E.N.T, Institute of E.N.T Shenzhen, Shenzhen, China. pcy2356@163.com.ORCID http://orcid.org/0000-0002-6187-7602
Shenzhen University · CNLonggang Central Hospital · CNSouthern Medical University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-10-expressing regulatory B cells (B10 cells) are dysfunctional in patients with many immune disorders. The underlying mechanism remains to be further elucidated. Glutamine is an essential nutrient for cell metabolism. This study aims to elucidate the role of glutaminolysis in maintaining the immune regulatory capacity in B10 cells. Peripheral blood samples were collected from 50 patients with allergic rhinitis and 50 healthy control subjects. B cells were isolated from blood samples by cell sorting with flow cytometry. The role of glutaminolysis in regulating B10 cell activities was assessed by immunological and biochemical approaches. The results showed that B cells from patients with allergic rhinitis expressed low levels of the transporter of glutamine and neutral amino acid. Glutaminolysis was required in the IL-10 expression in B cells. The glutamine catabolism was required in B10 cell generation. The mTOR activation mediated the glutaminolysis-associated B10 cell induction, and the suppression of the B cell glycogen synthase kinase-3 (GSK3) activation. GSK3 activation suppressed IL-10 expression in B cells. Inhibition of GSK3 enhanced IL-10 expression in B cells and alleviated experimental allergic rhinitis by generating immune competent type 1 regulatory T cells.

Indexed as

B-Lymphocytes, RegulatoryGlycogen Synthase Kinase 3CD4-Positive T-LymphocytesFlow CytometryHumansLymphocyte CountGlycogen Synthase Kinase 3

Identifiers

PMID35013572
OpenAlexW4205962375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.